Chartwell Retirement Residences

TSX:CSH.UN Stock Report

Market Cap: CA$4.4b

Chartwell Retirement Residences Valuation

Is CSH.UN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CSH.UN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CSH.UN (CA$16.05) is trading above our estimate of fair value (CA$0.15)

Significantly Below Fair Value: CSH.UN is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CSH.UN?

Key metric: As CSH.UN is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for CSH.UN. This is calculated by dividing CSH.UN's market cap by their current revenue.
What is CSH.UN's PS Ratio?
PS Ratio5.3x
SalesCA$818.59m
Market CapCA$4.42b

Price to Sales Ratio vs Peers

How does CSH.UN's PS Ratio compare to its peers?

The above table shows the PS ratio for CSH.UN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1x
SIA Sienna Senior Living
1.6x7.1%CA$1.4b
EXE Extendicare
0.6x2.5%CA$842.2m
DR Medical Facilities
0.6x-14.3%CA$369.6m
DNTL dentalcorp Holdings
1.2x9.8%CA$1.8b
CSH.UN Chartwell Retirement Residences
5.3x12.2%CA$4.4b

Price-To-Sales vs Peers: CSH.UN is expensive based on its Price-To-Sales Ratio (5.3x) compared to the peer average (1x).

Price to Sales Ratio vs Industry

How does CSH.UN's PS Ratio compare vs other companies in the CA Healthcare Industry?

8 CompaniesPrice / SalesEstimated GrowthMarket Cap
DOC CloudMD Software & Services
0.1xn/aUS$7.82m
NPTH NeuPath Health
0.1xn/aUS$6.45m
PHA Premier Health of America
0.05x4.3%US$5.56m
BLMH Bloom Health Partners
0.1xn/aUS$2.85m
CSH.UN 5.3xIndustry Avg. 1.0xNo. of Companies8PS00.61.21.82.43+
8 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: CSH.UN is expensive based on its Price-To-Sales Ratio (5.3x) compared to the North American Healthcare industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is CSH.UN's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CSH.UN PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio5.3x
Fair PS Ratio2.8x

Price-To-Sales vs Fair Ratio: CSH.UN is expensive based on its Price-To-Sales Ratio (5.3x) compared to the estimated Fair Price-To-Sales Ratio (2.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CSH.UN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCA$16.05
CA$18.18
+13.3%
3.5%CA$19.00CA$17.25n/a7
Nov ’25CA$15.56
CA$16.96
+9.0%
6.6%CA$18.50CA$15.25n/a7
Oct ’25CA$15.33
CA$16.21
+5.8%
5.9%CA$18.00CA$14.50n/a7
Sep ’25CA$14.59
CA$15.93
+9.2%
4.6%CA$17.00CA$14.50n/a7
Aug ’25CA$13.65
CA$15.07
+10.4%
3.7%CA$16.00CA$14.00n/a7
Jul ’25CA$12.85
CA$15.30
+19.1%
2.6%CA$16.00CA$15.00n/a5
Jun ’25CA$12.47
CA$15.10
+21.1%
4.4%CA$16.00CA$14.00n/a5
May ’25CA$12.48
CA$14.60
+17.0%
3.4%CA$15.00CA$14.00n/a5
Apr ’25CA$12.35
CA$14.50
+17.4%
3.4%CA$15.00CA$14.00n/a4
Jan ’25CA$11.72
CA$13.63
+16.3%
4.8%CA$14.00CA$12.50n/a4
Dec ’24CA$11.18
CA$13.25
+18.5%
5.7%CA$14.00CA$12.50n/a4
Nov ’24CA$10.31
CA$12.63
+22.5%
3.3%CA$13.00CA$12.00CA$15.564
Oct ’24CA$10.28
CA$12.40
+20.6%
4.7%CA$13.00CA$11.50CA$15.335
Sep ’24CA$10.54
CA$12.20
+15.7%
5.6%CA$13.00CA$11.50CA$14.595
Aug ’24CA$10.05
CA$11.40
+13.4%
5.1%CA$12.00CA$10.50CA$13.655
Jul ’24CA$9.47
CA$11.60
+22.5%
3.2%CA$12.00CA$11.00CA$12.855
Jun ’24CA$8.98
CA$11.60
+29.2%
3.2%CA$12.00CA$11.00CA$12.475
May ’24CA$8.87
CA$11.40
+28.5%
3.3%CA$12.00CA$11.00CA$12.485
Apr ’24CA$8.55
CA$11.30
+32.2%
3.5%CA$12.00CA$11.00CA$12.355
Mar ’24CA$8.86
CA$11.40
+28.7%
4.3%CA$12.00CA$11.00CA$12.395
Feb ’24CA$9.73
CA$11.40
+17.2%
4.3%CA$12.00CA$11.00CA$12.075
Jan ’24CA$8.44
CA$11.33
+34.3%
6.6%CA$12.00CA$10.00CA$11.726
Dec ’23CA$8.29
CA$11.33
+36.7%
6.6%CA$12.00CA$10.00CA$11.186
Nov ’23CA$7.88
CA$12.04
+52.8%
12.0%CA$14.25CA$10.00CA$10.316

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

NeuPath Health

CA$9.0m

Provides chronic pain management services in Canada.

NPTH

CA$0.17

7D

6.3%

1Y

9.7%

Medical Facilities

CA$369.6m

Through its subsidiaries, owns and operates specialty hospitals and ambulatory surgery center in the United States.

DR

CA$15.55

7D

3.2%

1Y

79.1%

Carebook Technologies

CA$6.2m

Engages in the development and commercialization of digital health platforms for assessments, reporting, and targeted solutions in Canada, the United States, Europe, Latin America, Asia, and internationally.

CRBK

CA$0.05

7D

-37.5%

1Y

-28.6%